Targeted partial breast radiotherapy reduces adverse events in early-stage breast cancer

Breast cancer patients who underwent targeted radiotherapy experienced fewer adverse events 5 years post-treatment than patients who had whole breast radiotherapy, a new study found.
Specialty Pharmacy Times